Congenital bilateral absence of the vas deferens (CBAVD) found in otherwise healthy infertile males, is associated with a high incidence of mutated cystic fibrosis transmembrane conductance regulator (CFTR) alleles, and is considered a genital form of cystic fibrosis (CF). The CF gene may also be involved in the aetiology of male infertility in cases other than CBAVD. The present study was undertaken to test the involvment of CFTR gene mutations in 14 CBAVD males and additionally in cases of male infertility caused by obstructive azoospermia (n ⍧ 10) and severe oligozoospermia (n ⍧ 3). The entire coding region of the CFTR gene was analysed using denaturing gradient gel electrophoresis (DGGE). The three allele (5T, 7T, 9T) polymorphic tract of thymidines in intron 8 (IVS8-polyT) of which the 5T allele acts as a mild mutation, causing reduced levels of normal CFTR mRNA due to deletion of exon 9, was also analysed. Of the 14 CBAVD cases, four (28.6%) were found to have mutations in both copies of the CFTR gene, six (42.8%) had one CFTR mutation, and in the remaining four (28.6%) no CFTR mutations were found. Of the 10 cases with obstructive azoospermia, three (30%) had one CFTR mutation and in the remaining seven (70%) no mutations were found. None of the three severe oligozoospermia cases carried a CFTR mutation. The frequency of the IVS8(5T) allele was 14.3% (4/28) for the CBAVD cases and 5% (1/20) for the obstructive azoospermia cases, none of the severe oligozoospermia males carried the IVS8-5(5T) allele. The data indicate that while there is a strong association between male infertility caused by CBAVD and mutations in the CFTR gene, cases of obstructive azoospermia without CBAVD also seem to be associated with CFTR gene mutations.
Introduction
Cystic fibrosis (CF) is one of the most common autosomal recessive disease in Caucasians, with a reported incidence of 1 in 2500 (Welsh et al., 1995) . It is caused by defects in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes a protein that functions as a chloride channel and is located in the apical membrane of epithelial cells in the respiratory tubes, pancreas, intestine, sweat glands and vas deferens. Defects in the CFTR gene cause abnormal chloride concentrations along the apical membrane of epithelial cells resulting in progressive lung disease, pancreatic dysfunction, elevated sweat chloride and male infertility (Welsh et al., 1995) . Infertility in CF males results from congenital bilateral absence or atrophy of the vas deferens (CBAVD).The body of the epididymis is also affected but the testicular efferent ducts tend to be spared and some may be dilated. Semen analysis reveals azoospermia (Trezise et al., 1993; Dodge, 1995) .
Some male patients present with isolated CBAVD with none of the clinical symptoms characteristic of CF. Mutation analysis of the CFTR gene in CBAVD cases, has shown that a large proportion of these sterile men carry a mutation in at least one of their CFTR genes (Anguiano et al., 1992; Mercier et al., 1995; Pauer et al., 1997) . The inability to identify a second mutation in most of the patients with CBAVD, even after the entire coding region of the gene is analysed, suggested that mutations could be located elsewhere in the non-coding regions of the gene. These mutations could cause CFTR levels below the minimum 12% necessary for normal protein function (Estivill, 1996) and could cause disease to organs most sensitive to CFTR dysfunction, such as the vas deferens (Tizzano et al., 1993; Teng et al.,1997) .
Whether or not CFTR mRNA contains exon 9 depends on the variable length of a sequence of thymines 5 bp upstream of exon 9. This sequence, known as a polyT sequence, contains five, seven or nine thymines (5T, 7T, and 9T allele system). There is a positive correlation between the IVS8-polyT genotype and the proportion of normal full length CFTR mRNA transcripts containing exon 9. The IVS8(5T) allele results in reduced levels of normal CFTR mRNA due to the deletion of exon 9, and is considered to be a disease mutation in CBAVD (Chillon et al., 1995; Costes et al., 1995) . Patients homozygous for the 5T allele have non-functional CFTR mRNA accounting for up to 90% of the total mRNA. The protein product of the CFTR transcript lacking exon 9, is devoid of cAMP-activated chloride conductance (Chu et al., 1993; Mak et al., 1997; Teng et al., 1997) .
Recently, there have also been reports of increased frequency of CF mutations in healthy men with reduced sperm quality and in men with obstructive azoospermia, with the presence of the vas deferens (Van der Ven et al., 1996; . It has been suggested tht the CFTR protein may also be involved in the process of spermatogenesis or sperm maturation apart from playing a role in the development of the epididymal glands and the vas deferens. Evidence for this is the fact that maximal CFTR expression is seen in round spermatids in rodents which immediately precedes nuclear condensation and simultaneous decreases in cytoplasmic volume, suggesting a physiological role for CFTR as a chloride channel during spermatogenesis (Trezise et al., 1993) . Histological descriptions of testicular tissue in men with clinical CF and CBAVD emphasize a high number of cytological abnormalities that preferentially occur in the spermatid stage (Gottlieb et al., 1991) . The major objective of this study was to evaluate the frequency and nature of mutations in the CFTR gene in healthy men with CBAVD, in men with azoospermia without CBAVD (ObsA) and in cases of severe oligozoospermia.
Materials and methods

Sample composition
Male subjects (n ϭ 27) suffering from infertility with azoospermia (14 CBAVD and 10 ObsA) or severe oligozoospermia (n ϭ 3 cases), were studied. The patients were referred to us from the infertility clinic of the First Department of Obstetrics and Gynaecology, University of Athens and the Embryogenesis Centre for Reproductive and Fertility studies, Athens, Greece. The diagnosis of CBAVD was based on the small volume of ejaculate and complete absence of spermatozoa, and the typical biochemical changes found in vas deferens agenesis: increased semen acidity (pH Ͻ7), absence or decreased concentrations of fructose, decreased concentrations of L-carnitine, and normal concentrations of plasma follicle stimulating hormone (FSH). The presence of the vas deferens in the 10 males with obstructive azoospermia was confirmed by clinical examination. None of the patients had any of the classic symptoms of CF. Sweat electrolytes were estimated on all patients. Chloride levels Ͼ60 mEq/l were considered as positive, 40-60 mEq/l as borderline and Ͻ40 mEq/l as negative. The selection of patients was not based on raised sweat electrolytes. Renal ultrasound was not performed on the CBAVD patients in order to exclude renal agenesis as the cause of CBAVD.
Mutation analysis
Genomic DNA was extracted from white blood cells as previously described by Miller et al. (1988) . The presence of mutations in the 27 exons of the CFTR gene was assessed by denaturing gradient gel electrophoresis (DGGE) following simple or multiplex polymerase chain reaction (PCR) of patient DNA.
PCR was performed on 0.1-1 µg of DNA in a Trio Block thermal cycler (Biometra, Kent, UK) with standard conditions for all the exons and for 40 PCR cycles, consisting of 1 min at 94°C, 1 min at 55°C and 2 min at 72°C. Each primer was used at 25 pmol in a 50 µl reaction. One of the primers of the pair for each exon has an additional GC sequence, usually 40-50 bp, attached to the 5Ј end of the normal sequence of the primer. The sequence of the primers used was that described by Fanen et al. (1992) .
For the multiplex exon PCR the reaction was performed as above for 40 PCR cycles, except that each reaction included three pairs of primers for each multiplex. Multiplex A ϭ exons 11-14b-17b; multiplex B ϭ exons 14a-15-20; multiplex C ϭ exons 3-12-23; multiplex D ϭ exons 6a-9-21 and multiplex E ϭ exons 5-8-18. The annealing temperature was specific for each multiplex PCR, as described by Costes et al. (1993) . The three fragments for each exon amplified in a single reaction for each DNA sample were analysed in a single lane of the denaturing gel.
The gel apparatus used was described by Attree et al. (1989) . Each amplified DNA sample (15 µl) was subjected to electrophoresis at 160 V in a 6.5% polyacrylamide gel containing a linearly increasing denaturant gradient (100% denaturant is 7 M urea and 40% formamide). The electrophoretic conditions, including the range of denaturant concentrations and the run times were as described by Fanen et al. (1992) , except that exon 1 was run at a denaturant range of 30-80% for 12 h, exon 7 at a denaturant range of 10-80% for 12 h. Exon 13 was run in two fragments using primer pairs GCCF1311/CF1312 and CF1321/CF1323 at a denaturant range of 10-60% for 5 h.
All DNA samples showing a shift in DGGE mobility and not presenting a pattern of a known mutation were sequenced using an automatic DNA sequencer (Vistra, model 725; Molecular Dynamics, CA, USA) for the identification of the mutation. Dideoxy sequencing reactions were performed on double stranded DNA using Texas Redlabelled primers, which have a single fluorescent moiety covalently coupled to their 5Ј end, and the dye-primer sequencing kit containing sequenase polymerase (Amersham, UK). The Macintosh computer software (Vistra 725 version 2.0) performed all the data collection and processing functions.
The intron 8 thymidine (IVS8-5 poly T) tract was firstly analysed as described by Chillon et al. (1995) , and was further confirmed using an allele-specific PCR assay, which readily distinguished between the 5T, 7T and 9T alleles. The conditions for the allelespecific PCR were as described by Friedman et al., 1997 , with the exception that Amplitaq-Gold (Perkin Elmer-Roche, CA, USA) was used as a thermostable polymerase. In addition an internal control primer pair: (Gγ-Direct: 5ЈAGTGCTGCAAGAAGAACAACTACC 3Ј; Gγ-Reverse: 5ЈCTCTGCATCATGGGCAGTGAGCTC 3Ј) was used which amplifies a 323 bp fragment 3Ј to the Gγ globin gene.
Results
The analysis of the entire coding sequence identified 12 different molecular defects including ∆F508, and two are novel defects (D565G and 2790-8CϾG) ( Table I) . Of the two novel mutations, one was identified in a CBAVD case and is a missence mutation D565G, the other is a possible splicing defect 2790-8CϾG and was detected in a male with obstructive azoospermia.
Among the 14 CBAVD patients, four were compound heterozygotes (28.6%) for CFTR coding sequence mutations, but only two had sweat chloride levels Ͼ60 mEq/l, one (∆F508/M1I) also carried one 5T allele. Six (42.8%) had one CF mutation, and three of them with mutations ∆F508, L732X, 711ϩ3AϾG, are also 5T heterozygotes. Finally in four CBAVD patients (28.6%) no mutation was detected (Table I ). The frequency of the IVS8(5T) allele among the CBAVD males was 14.3% (Table II) .
Among the 10 men with obstructive azoospermia, three (30%) had one CF mutation and in seven (70%) no mutations were detected (Table I ). All of the men with obstructive azoospermia had sweat test values Ͻ60 mEq/l, and only three had values of 40-60 mEq/l, which is considered borderline. The frequency of the IVS8(5T) allele among the ObsA cases One mutation detected (10) *Frequencies in the general population are: 5T, 5.2%; 7T, 83.3%; 9T, 11.5% (Chillon et al., 1995) . CBAVD ϭ congenital bilateral absence of the vas deferens; ObsA ϭ obstructive azoopermia.
was 5.0% (Table II ) (∆F508/-and 5T/9T). No CFTR mutations were detected in the three cases of severe oligozoospermia, the sweat chloride values were normal (40-50 mEq/l) and all were homozygous for the IVS8(7T) allele.
Discussion
CF-related infertility in men is primarily due to obstruction or absence of the vas deferens (Welsh et al., 1995) though a defect in spermatogenesis may be a contributing factor, as decreased numbers of mature spermatids and the presence of many malformed late spermatids are also found in CF (Trezise et al., 1993) . The relationship between CBAVD and CF gene mutations has previously been demonstrated (Anguiano et al., 1992; Osborne et al., 1993; Chillon et al., 1995; Costes et al., 1995; 335 Mercier et al., 1995; Colin et al., 1996; Pauer et al., 1997) . In the majority of cases mutations have been found in only one CF allele (10-20% are compound heterozygotes, 40-60% CF heterozygotes and 20-50% have no CFTR gene mutations). The inability to identify the second mutation in most patients with CBAVD suggested that mutations could be located elsewhere in the non-coding regions of the gene.
These mutations may produce CFTR protein with low levels of expression (8-10% of normal) and thus cause disease in the vas deferens tissue and not in other organs affected by cystic fibrosis (Stern, 1997; Teng et al., 1997) . Reduced levels of normal CFTR mRNA due to the deletion of exon 9 depend on the presence of the 5T allele sequence in intron 8. This non-functional CFTR mRNA accounts for up to 90% of the total mRNA when both CFTR alleles have the 5T allele (Chu et al., 1993) . The IVS8(5T) allele is the most common CFTR defect in patients with obstructive azoospermia due to CBAVD (Chillon et al., 1995; Estivill, 1996) .
Increased frequency of CF mutations in healthy men with reduced sperm quality and also in men with obstructive azoospermia with the presence of the vas deferens, has also been reported (Van der Ven et al., 1996; .
Our results show that of the CBAVD men 28.6% were compound heterozygotes, 42.8% had one CF mutation and in 28.6% no mutation was detected. The frequency of the 5T allele among CBAVD males was 14.3%, 3-fold higher than in normal chromosomes. The results agree with other studies done on CBAVD males (Chillon et al., 1995; Costes et al., 1995; Colin et al., 1996; Pauer et al., 1997) . No mutation, except for ∆F508, was prevalent in individuals in this study and all of the mutations found in the CBAVD patients, except for the novel D565G and mutation R668C, have also been found in Greek CF patients (Tzetis et al., 1977) .
The novel missence mutation D565G has not been detected in Ͼ250 CF chromosomes, nor in Ͼ100 non-CF chromosomes that we have examined. The substitution produced by mutation D565G involves a change of a positively charged for a polar uncharged amino acid in exon 12 of the gene. The aspartic acid at position 565 is conserved among species (Tucker et al., 1992) . R668C was initially reported as a polymorphism but has since been reported as a mutation in cases of disseminated bronchiectasis (DB) and in CBAVD (Chillon et al., 1995; Pignatti et al., 1996) .
In only two of the four compound heterozygote CBAVD patients the sweat test was Ͼ60 mEq/l (considered positive). Furthermore, three of the 14 CBAVD patients also presented a few clinical symptoms related to CF.
The ∆F508/M1I patient, also a carrier of the IVS8(5T) allele, which is probably linked to the M1I mutation since the 9T allele is reported to be in absolute linkage disequilibrium with the ∆F508 mutation (Chu et al., 1993) , had a sweat test of 107.7 mEq/l and has, since his diagnosis, been coming to the CF clinic every 6 months for clinical follow-up of his pulmonary condition due to episodes of recurrent bronchitis. Patient MS6 (∆F508/ 711ϩ3AϾG), is currently 36 years old, had sweat test value of 74.5 mE/l, and presented no other CF symptoms except for a chronic cough. Patient MS15 (L732X/-) who is also heterozygous for the 5T allele and thus could be considered to be a CF compound heterozygote, had a severe dehydration episode and few gastrointestinal manifestations of CF.
Of the 10 men with obstructive azoospermia, three (30%) were CFTR heterozygotes and in the remaining seven (70%) no mutations were found in the coding region of the gene. The novel mutation 2790-8CϾG, detected in patient MS23, occurs at the pyrimidine stretch next to the splice acceptor site of intron 14b, the C→G transversion could determine the utilization of the branch-site and the 3Јss, therefore affecting splicing efficiency of exon 15 (Krawczak et al., 1992) . This novel mutation has not been detected in Ͼ250 CF chromosomes that we have examined. The frequency of the IVS8(5T) allele was 5% (1/20) which is the same as the frequency for the general population, in agreement with the report by Chillon et al. (1995) , where males with obstructive azoospermia but without CBAVD were reported to present a 5T allele frequency similar to the general population. The sweat test was borderline positive (40-60 mEq/l) in three patients. None of the men with obstructive azoospermia presented pulmonary or gastrointestinal manifestations of CF. The high frequency of CFTR mutations in males with obstructive azoospermia (15%), suggests that the CFTR protein may play a critical role in spermatogenesis or sperm maturation that is independent of its function in the development of epithelial ducts such as the vas deferens (Trezise et al., 1993; Van der Ven et al., 1996; .
Finally in the three oligozoospermic males, no CFTR mutations were detected and all three were homozygous for the IVS8(7T) allele. These results imply that other genes, including the AZF genes (In't Veld et al., 1997; Kretser and Burger, 1997; Meschede and Horst, 1997; Pryor et al., 1997) could be responsible for their infertility.
In conclusion, CFTR mutations may represent one of the most common abnormalities associated with male infertility. Especially with CBAVD (CFTR mutation frequency 50%) but also in obstructive azoospermia (CFTR mutation frequency 15%). These results are also relevant with regard to genetic counselling for infertile patients treated by in-vitro fertilization (IVF). An increasing number of couples with infertility choose to be treated by assisted-fertilization methods such as intracytoplasmic sperm injection (ICSI); partners of CF-positive CBAVD or males with obstructive azoospermia should also be tested for the most common CF mutations in the population, so that prenatal diagnosis can be offered if both are carriers.
One such case was assessed in our unit where a CF mutation (∆F508) was characterized in a CBAVD male and also in his wife. ICSI resulted in a twin pregnancy and prenatal diagnosis identified one heterozygous and one CF affected fetus. Furthermore, these couples would also be perfect candidates for the application of preimplantation genetic diagnosis. The birth of a normal girl after IVF and preimplantation genetic diagnosis for ∆F508 has already been done by Handyside et al. (1992) . It could also be possible to perform preimplantation genetic diagnosis for other CFTR mutations by multiplex first round PCR of the two exons harbouring the mutations of the parents and DGGE second round PCR for the detection of the mutations. The same procedure has been applied experimentally in our laboratory in order to establish preimplantation genetic diagnosis for β-thalassaemia (Palmer et al., 1996) .
Finally, patients with CBAVD who have a positive sweat test and are compound heterozygotes for two CFTR mutations or one CFTR mutation/and the IVS8(5T) allele probably warrant clinical follow-up for potential late complications of CF, since the lifetime risk of developing pulmonary disease is unknown, and advice on persistent pulmonary symptoms could be beneficial.
